0001123292-15-001130.txt : 20150821
0001123292-15-001130.hdr.sgml : 20150821
20150821192659
ACCESSION NUMBER: 0001123292-15-001130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150820
FILED AS OF DATE: 20150821
DATE AS OF CHANGE: 20150821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sarena Francis Willard
CENTRAL INDEX KEY: 0001423786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 151069739
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: 2 CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-20
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001423786
Sarena Francis Willard
C/O FIVE PRIME THERAPEUTICS, INC.
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, Gen Counsel & Secretary
Common Stock
2015-08-20
4
A
0
75000
0
A
83570
D
Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on September 1, 2016 with the remainder vesting on March 1, 2017, provided the reporting person remains employed by the company through each such date.
/s/ Francis Sarena
2015-08-21